<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome (AS)</z:e> is a disorder of human cognition characterized by <z:hpo ids='HP_0010864'>severe mental retardation</z:hpo> and <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Recently, a mouse model for AS (Ube3a maternal null mutation) was developed that displays deficits in both context-dependent learning and hippocampal long-term potentiation (LTP) </plain></SENT>
<SENT sid="2" pm="."><plain>In the present studies, we examined the molecular basis for these LTP and learning deficits </plain></SENT>
<SENT sid="3" pm="."><plain>Mutant animals exhibited a significant increase in hippocampal phospho-calcium/calmodulin-dependent protein kinase II (CaMKII), specifically at sites Thr(286) and Thr(305), with no corresponding change in the levels of total CaMKII </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, mutants show a reduction in CaMKII activity, autophosphorylation capability, and total CaMKII associated with postsynaptic density </plain></SENT>
<SENT sid="5" pm="."><plain>These findings are the first to implicate misregulation of CaMKII as a molecular cause for the neurobehavioral deficits in a human <z:e sem="disease" ids="C0023186" disease_type="Mental or Behavioral Dysfunction" abbrv="">learning disorder</z:e> </plain></SENT>
</text></document>